Extracting Apathy From Depression Syndrome in Traumatic Brain Injury by Using a Clustering Method.


Journal

The Journal of neuropsychiatry and clinical neurosciences
ISSN: 1545-7222
Titre abrégé: J Neuropsychiatry Clin Neurosci
Pays: United States
ID NLM: 8911344

Informations de publication

Date de publication:
2022
Historique:
pubmed: 20 11 2021
medline: 4 5 2022
entrez: 19 11 2021
Statut: ppublish

Résumé

Depression and apathy are common after traumatic brain injury (TBI), and different intervention strategies are recommended for each. However, a differential diagnosis can be difficult in clinical settings, especially given that apathy is considered to be a symptom of depression. In this study, the investigators aimed to isolate apathy from depression among patients with TBI and to examine whether apathy is exclusively associated with the amount of daily activity, as previously reported in the literature. Eighty-eight patients with chronic TBI completed the Japanese versions of the 21-item Beck Depression Inventory-II (BDI-II) and the Starkstein Apathy Scale (AS). Daily activity was measured with a 24-hour life log. A hierarchical cluster analysis was applied to divide the BDI-II data into separable components, and components' correlations with results of the AS and 24-hour life log scale were evaluated. The BDI-II and AS revealed that 37 patients (42.0%) had both depression and apathy. BDI-II data were classified into four separate clusters (somatic symptoms, loss of self-worth, affective symptoms, and apathy symptoms). Loss of self-worth and apathy symptoms subscores were significantly positively correlated with total AS score (r=0.32, p=0.002, and r=0.52, p<0.001, respectively). The apathy symptoms subscore was significantly correlated with the amount of daily activity (r=-0.29, p=0.009). The findings suggest that the BDI-II can differentiate between apathy and depression among patients with TBI, which is essential when selecting intervention options. Moreover, apathy symptoms predicted patients' real-life daily activity.

Identifiants

pubmed: 34794328
doi: 10.1176/appi.neuropsych.21020046
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

158-167

Auteurs

Shiho Ubukata (S)

Medical Innovation Center (Ubukata, Oishi) and Department of Psychiatry (Ueda, Fujimoto, Ueno, Murai), Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Keita Ueda (K)

Medical Innovation Center (Ubukata, Oishi) and Department of Psychiatry (Ueda, Fujimoto, Ueno, Murai), Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Gaku Fujimoto (G)

Medical Innovation Center (Ubukata, Oishi) and Department of Psychiatry (Ueda, Fujimoto, Ueno, Murai), Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Senkei Ueno (S)

Medical Innovation Center (Ubukata, Oishi) and Department of Psychiatry (Ueda, Fujimoto, Ueno, Murai), Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Toshiya Murai (T)

Medical Innovation Center (Ubukata, Oishi) and Department of Psychiatry (Ueda, Fujimoto, Ueno, Murai), Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Naoya Oishi (N)

Medical Innovation Center (Ubukata, Oishi) and Department of Psychiatry (Ueda, Fujimoto, Ueno, Murai), Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH